Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank13
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P13
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| 2024 | -35.89% |
| 2023 | -37.15% |
| 2022 | -35.70% |
| 2021 | -28.44% |
| 2020 | -16.24% |
| 2019 | 24.94% |
| 2018 | 82.13% |
| 2017 | 44.31% |
| 2016 | 0.00% |